Pycnogenol for Menopausal Symptoms

Clinical Trial Title The Use of Pycnogenol® to Alleviate Menopausal Symptoms Induced or Increased by Breast and Gynecological Cancer Treatments
Trial Status Closed to Enrollment
Start Date 10/10/2018
Location Doctors & Locations
Trial Type Cancer - Adult Oncology
Specific Condition Breast Cancer
Description This is a pilot study to test whether PYC can improve climacteric symptoms for women who have experienced either surgically or medically induced menopause as part of their treatment for breast or gynecologic cancers.
Eligibility Criteria

Inclusion Criteria:

  • Patient currently is undergoing treatment for cancer
  • Patient has menopausal symptoms induced either by surgical or medical (patient on tamoxifen or aromatase inhibitor) interventions for cancer
  • Willing to stop other supplements or medications that are aimed at treating menopausal symptoms at least 7 days before beginning study treatment

Exclusion Criteria:

  • Menopausal symptoms are unrelated to surgical or medical treatment of breast or gynecologic cancers

Please contact Legacy Oncology Research for additional study inclusion/exclusion information.

 
IRB Number Central IRB
Notes https://clinicaltrials.gov/ct2/show/NCT03704454?term=pycnogenol&cond=menopausal+symptoms
Principal Investigator Reza Antoszewska, MS NP-C
Contact Name Oncology Clinical Research
Contact Phone 503-413-8199
Contact Fax 503-413-6920
Contact E-Mail oncologyresearch@lhs.org